Literature DB >> 16289004

Smad3 phosphorylation by cyclin-dependent kinases.

Fang Liu1.   

Abstract

Smad3, a key mediator for TGF-beta antiproliferative responses, is phosphorylated by both CDK4 and CDK2 in vivo and in vitro. Except for the Rb family members, Smad3 is the only CDK4 substrate demonstrated so far. CDK phosphorylation of Smad3 inhibits its transcriptional activity and antiproliferative function. Because cancer cells often contain high levels of CDK activity, inhibition of Smad activity by CDK phosphorylation may contribute to tumorigenesis and TGF-beta resistance in cancers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16289004     DOI: 10.1016/j.cytogfr.2005.09.010

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  32 in total

Review 1.  Aging of signal transduction pathways, and pathology.

Authors:  Morgan E Carlson; Haroldo S Silva; Irina M Conboy
Journal:  Exp Cell Res       Date:  2008-04-07       Impact factor: 3.905

2.  SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.

Authors:  Sheng Liu; Thao Nheu; Rodney Luwor; Sandra E Nicholson; Hong-Jian Zhu
Journal:  J Biol Chem       Date:  2015-06-01       Impact factor: 5.157

3.  Cyclin-dependent kinase 4-mediated phosphorylation inhibits Smad3 activity in cyclin D-overexpressing breast cancer cells.

Authors:  Stanislav Zelivianski; Anne Cooley; Ron Kall; Jacqueline S Jeruss
Journal:  Mol Cancer Res       Date:  2010-08-24       Impact factor: 5.852

Review 4.  Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma.

Authors:  Miki Murata; Katsunori Yoshida; Takashi Yamaguchi; Koichi Matsuzaki
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

Review 5.  Resistance to transforming growth factor β-mediated tumor suppression in melanoma: are multiple mechanisms in place?

Authors:  Ahmed Lasfar; Karine A Cohen-Solal
Journal:  Carcinogenesis       Date:  2010-07-23       Impact factor: 4.944

Review 6.  Cyclin D1, cancer progression, and opportunities in cancer treatment.

Authors:  Shuo Qie; J Alan Diehl
Journal:  J Mol Med (Berl)       Date:  2016-10-02       Impact factor: 4.599

7.  Transforming growth factor-{beta}-inducible phosphorylation of Smad3.

Authors:  Guannan Wang; Isao Matsuura; Dongming He; Fang Liu
Journal:  J Biol Chem       Date:  2009-02-13       Impact factor: 5.157

8.  Pin1 promotes transforming growth factor-beta-induced migration and invasion.

Authors:  Isao Matsuura; Keng-Nan Chiang; Chen-Yu Lai; Dongming He; Guannan Wang; Romila Ramkumar; Takafumi Uchida; Akihide Ryo; Kunping Lu; Fang Liu
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

9.  Regulation of the anaphase-promoting complex-separase cascade by transforming growth factor-beta modulates mitotic progression in bone marrow stromal cells.

Authors:  Takeo Fujita; Michael W Epperly; Hui Zou; Joel S Greenberger; Yong Wan
Journal:  Mol Biol Cell       Date:  2008-10-08       Impact factor: 4.138

10.  Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis.

Authors:  Everardo Macias; Yongbaek Kim; Paula L Miliani de Marval; Andres Klein-Szanto; Marcelo L Rodriguez-Puebla
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.